Posts filed under ‘GUIDELINES’

Update on pathogenesis and diagnosis of intravascular catheter-related infections.

Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 4:16-21.

Pascual A1, Cercenado E, Salavert M, Elías García-Sánchez J, Eiros JM, Liñares J, Fernández C, Vila J.

1Departamento de Microbiología, Hospital Universitario Virgen Macarena, Facultad de Medicina, Sevilla, Spain. apascual@us.es

Abstract

Infections associated with the use of intravascular catheters cause a substantial morbidity and mortality.

New knowledge in the pathogenesis of catheter related bloodstream infections has led to advances in the prevention and management of these infections.

The purpose of the present chapter is to review the most relevant data published recently on pathogenesis and diagnosis of intravascular catheter-related infections.

It is focus in four different aspects:

a) pathogenesis of catheter-related infections and particularly factors affecting biofilm formation and modulation;

b) pathogenesis of intravascular catheter-related infections caused by Staphylococcus lugdunensis; c) news on microbiological diagnosis of catheter-related bacteremia; and

d) evaluation of current use of blood cultures in the era of continuous monitoring blood cultures systems.

PDF english

http://apps.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=90002228&pident_usuario=0&pcontactid=&pident_revista=28&ty=140&accion=L&origen=zonadelectura&web=www.elsevier.es&lan=en&fichero=28v29nSupl.4a90002228pdf001.pdf

 

February 26, 2015 at 12:33 pm

GUIA de Atención de TBC Pulmonar y Extrapulmonar – Colombia

INDICE

  1. Introducción…………………………………………………………………………27
  2. Metodología………………………………………………………………………….27
  3. Justificación …………………………………………………………………………28
  4. Epidemiología……………………………………………………………………….29
  5. Objetivos …………………………………………………………………………….31

5.1 Objetivos generales……………………………………………………………… ..31

5.2 Objetivos específicos …………………………………………………………….. 31

  1. Población objeto…………………………………………………………………. 32
  2. Definición ………………………………………………………………………….. 32
  3. Etiopatogenia…………………………………………………………………….. 32
  4. Historia natural de la tuberculosis…………………………………… …37
  5. Diagnóstico de la enfermedad tuberculosa………………………. …39

10.1 Tuberculosis pulmonar…………………………………………………….. …41

10.2 Tuberculosis extrapulmonar…………………………………………… ….45

10.3 Tuberculosis pleural ………………………………………………………….. 46

10.4 Tuberculosis ganglionar …………………………………………………….. 47

10.5 Tuberculosis genitourinaria ………………………………………………. 48

10.6 Tuberculosis osteoarticular ……………………………………………… ..48

10.7 Tuberculosis del sistema nervioso central ……………………… ….49

10.8 Tuberculosis abdominal ……………………………………………………. 50

10.9 Pericarditis tuberculosa………………………………………………………. 50

10.10 Tuberculosis hematógena ………………………………………………… 51

  1. Diagnóstico de la infección tuberculosa ………………………………51

11.1 Tuberculina ………………………………………………………………………..51

11.2 Indicaciones de la prueba tuberculínica …………………………. ….52

11.3 Aplicación y lectura ……………………………………………………………. 53

11.4 Interpretación de la tuberculina……………………………………… ….54

  1. Tratamiento de la tuberculosis………………………………………….. 55

12.1 Fármacos antituberculosos ………………………………………………… 56

12.2 Esquemas de tratamiento recomendados ………………………….. 57

12.3 Retratamientos …………………………………………………………………. 65

12.4 Tuberculosis multirresistente …………………………………………… 68

12.5 Tratamiento de la infección tuberculosa latente ……………….. 69

  1. Vacuna BCG ……………………………………………………………………. 78
  2. Manejo en situaciones especiales …………………………………….. 80

14.1Tuberculosis y VIH ……………………………………………………………. 80

14.2 Tuberculosis infantil …………………………………………………………. 84

  1. Manejo en situaciones particulares ………………………………….. 87

15.1 Embarazo …………………………………………………………………………. 87

15.2 Enfermedad hepática ……………………………………………………….. 88

15.3 Insuficiencia renal ……………………………………………………………. 88

15.4 Silicotuberculosis …………………………………………………………….. 88

15.5 Tuberculosis y diabetes …………………………………………………… 88

15.6 Tuberculosis pulmonar negativa al cultivo………………………… 88

  1. Otras medidas no medicamentosas …………………………………. 89

16.1 Cirugía en Ttuberculosis …………………………………………………… 89

16.2 Esteroides en tuberculosis………………………………………………… 89

16.3 Hospitalización en tuberculosis …………………………………………. 90

  1. Actividades de vigilancia en salud pública………………………… 90
  2. Flujogramas …………………………………………………………………….. 91

Anexo ………………………………………………………………………………………. 94

Bibliografía (153 citas) ……………………………………………………………… 96

 

Tablas – Gráficos

Tabla 1. Grado de recomendación y nivel de evidencia ………………. 28

Tabla 2. Indicaciones de la American Thoracic Society ………………. 55

Tabla 3. Presentaciones recomendadas por la OMS, drogas de dosis fijas ……………… ……………………………………………………………………………65

Tabla 4. Esquema básico …………………………………………………………… 66

Tabla 5. Esquema……………………………………………………………………………………. 69

Tabla 6. Tratamiento ………………………………………………………………… 73

Tabla 7. Tratamiento acortado supervisado ……………………………… 77

Tabla 8. Esquema de retratamiento supervisado………………………. 77

Tabla 9. Tratamiento acortado supervisado para tuberculosis pulmonar y extrapulmonar en menores de 15 años ………………….. 77

 

FLUJOGRAMAS

  1. Detección y diagnóstico de casos pulmonares…………………… 91
  2. Diagnóstico de casos extrapulmonares ……………………………. 92
  3. Tratamiento …………………………………………………………………… 92
  4. Seguimiento ……………………………………………………………………. 93

 

PDF

http://www.nacer.udea.edu.co/pdf/libros/guiamps/guias11.pdf

February 7, 2015 at 12:44 pm

EBOLA – Recomendaciones para la atención de pacientes en áreas críticas (33 págs)

Medicina Intensiva OCT 2014 V.31 N.4 Supl.

Sociedad Argentina de Terapia Intensiva (SATI)

Agradecemos al Comité de Infectología Crítica de la Sociedad Argentina de Terapia Intensiva por compartir su trabajo poniéndolo a disposición de los colegas de todos los países de habla hispana. El artículo fue publicado en la revista “Medicina Intensiva”.

El propóstio de este documento es proporcionar un enfoque práctico a los intensivistas ante la enfermedad por virus del Ébola, con especial énfasis en el diagnóstico y el tratamiento oportunos, como así también en la prevención de su diseminación a otros pacientes o al personal sanitario.

El documento se redactó sobre la base de las recomendaciones de los organismos internacionales y del Ministerio de Salud de la Nación, adaptándolas a la realidad local.

Documento imprescindible fundado en la mejor evidencia científica y con aplicaciones prácticas elaborado por el Comité de Infectología Crítica de la SATI.

 

INDICE

  1. Objetivos
  2. Aspectos epidemiológicos y transmisión del virus del Ébola
  3. Sistema de notificación
  4. Toma y derivación de muestras para diagnósticos por laboratorio específicos y de rutina
  5. Infraestructura y manejo de pacientes en áreas críticas
  6. Medidas de prevención y control de infecciones
  7. Atención del paciente en áreas críticas
  8. Anexos
  9. Bibliografía

 

PDF

http://www.intramed.net/userfiles/2015/file/Ebola_SATI.pdf

 

January 22, 2015 at 4:06 pm

Community acquired pneumonia. New guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR).

Arch Bronconeumol. 2010 Oct;46(10):543-58.

Menéndez R1, Torres A, Aspa J, Capelastegui A, Prat C, Rodríguez de Castro F; Sociedad Española de Neumología y Cirugía Torácica.

Author information

1Hospital Universitario La Fe, Valencia, CIBERES, España. rmenend@separ.es

PDF

http://apps.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=13156293&pident_usuario=0&pcontactid=&pident_revista=6&ty=66&accion=L&origen=bronco&web=www.archbronconeumol.org&lan=es&fichero=6v46n10a13156293pdf001.pdf

December 24, 2014 at 7:43 pm

Guidelines for the management of adult lower respiratory tract infections.

Clin Microbiol Infect. 2011 Nov;17 Suppl 6:E1-59.

Woodhead M1, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ; Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases.

Author information

1Department of Respiratory Medicine, Manchester Royal Infirmary, Oxford Road, Manchester, UK. mark.woodhead@cmft.nhs.uk

Abstract

This document is an update of Guidelines published in 2005 and now includes scientific publications through to May 2010.

It provides evidence-based recommendations for the most common management questions occurring in routine clinical practice in the management of adult patients with LRTI.

Topics include management outside hospital, management inside hospital (including community-acquired pneumonia (CAP), acute exacerbations of COPD (AECOPD), acute exacerbations of bronchiectasis) and prevention.

Background sections and graded evidence tables are also included.

The target audience for the Guideline is thus all those whose routine practice includes the management of adult LRTI.

FULL TEXT

http://www.sciencedirect.com/science/article/pii/S1198743X1461404X

PDF

http://ac.els-cdn.com/S1198743X1461404X/1-s2.0-S1198743X1461404X-main.pdf?_tid=ad8a9290-8ad4-11e4-b2b8-00000aacb35f&acdnat=1419360857_02381ba4527725534b4b9932bb543c24

December 23, 2014 at 3:54 pm

Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America

Clinical Infectious Diseases November 1, 2014 V.59 N.9 P.1203-1207

IDSA GUIDELINES

Gregory M. Lucas1, Michael J. Ross2, Peter G. Stock3, Michael G. Shlipak4, Christina M. Wyatt2, Samir K. Gupta5, Mohamed G. Atta1, Kara K. Wools-Kaloustian5, Paul A. Pham1, Leslie A. Bruggeman6, Jeffrey L. Lennox7, Patricio E. Ray8, and Robert C. Kalayjian6

1Johns Hopkins School of Medicine, Baltimore, Maryland

2Icahn School of Medicine at Mount Sinai, New York, New York

3University of California, San Francisco

4San Francisco Veteran Affairs Medical Center, California

5Indiana University School of Medicine, Indianapolis

6MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio

7Emory University School of Medicine, Atlanta, Georgia

8Children’s National Medical Center, Washington D.C.

Correspondence: Gregory M. Lucas, MD, PhD, Department of Medicine, Johns Hopkins University, 1830 E Monument St, 4th Floor, Baltimore, MD 21287 (glucas@jhmi.edu).

It is important to realize that guidelines cannot always account for individual variation among patients.

They are not intended to supplant physician judgment with respect to particular patients or special clinical situations.

IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient’s individual circumstances.

PDF

http://cid.oxfordjournals.org/content/59/9/1203.full.pdf+html

November 17, 2014 at 8:47 am

Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America

Clinical Infectious Diseases NOV 1, 2014 V.59 N.9 P.1203-1207

IDSA GUIDELINE

Gregory M. Lucas1, Michael J. Ross2, Peter G. Stock3, Michael G. Shlipak4, Christina M. Wyatt2, Samir K. Gupta5, Mohamed G. Atta1, Kara K. Wools-Kaloustian5, Paul A. Pham1, Leslie A. Bruggeman6, Jeffrey L. Lennox7, Patricio E. Ray8, and Robert C. Kalayjian6

1Johns Hopkins School of Medicine, Baltimore, Maryland

2Icahn School of Medicine at Mount Sinai, New York, New York

3University of California, San Francisco

4San Francisco Veteran Affairs Medical Center, California

5Indiana University School of Medicine, Indianapolis

6MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio

7Emory University School of Medicine, Atlanta, Georgia

8Children’s National Medical Center, Washington D.C.

Correspondence: Gregory M. Lucas, MD, PhD, Department of Medicine, Johns Hopkins University, 1830 E Monument St, 4th Floor, Baltimore, MD 21287 (glucas@jhmi.edu).

It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations.

IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient’s individual circumstances.

PDF

http://cid.oxfordjournals.org/content/59/9/1203.full.pdf+html

October 19, 2014 at 12:38 pm

Older Posts


Calendar

March 2015
M T W T F S S
« Feb    
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Posts by Month

Posts by Category


Follow

Get every new post delivered to your Inbox.

Join 80 other followers